{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:19:05Z","timestamp":1794745145790,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004933","name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Toxinas","doi-asserted-by":"publisher","award":["409148\/2024-5"],"award-info":[{"award-number":["409148\/2024-5"]}],"id":[{"id":"10.13039\/501100004933","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["24\/2551-0001307-05"],"award-info":[{"award-number":["24\/2551-0001307-05"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["22\/2551-0000385-0"],"award-info":[{"award-number":["22\/2551-0000385-0"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biopha.2026.119952","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:15:20Z","timestamp":1790460920000},"page":"119952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Spheroid maturation determines drug response and establishes a mechanism-informed framework for analytical endpoint validation in three-dimensional lung cancer models"],"prefix":"10.1016","volume":"204","author":[{"given":"J\u00e9ssica Eduarda","family":"dos Santos Batista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valqu\u00edria","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano Barbosa","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Klein","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduarda","family":"Silvestrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano Rizzotto","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Maria","family":"Zago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilda","family":"da Cruz Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9152-4229","authenticated-orcid":false,"given":"F\u00e1bio","family":"Klamt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119952_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41571-018-0102-3","article-title":"Accelerating anticancer drug development\u2014opportunities and trade-offs","volume":"15","author":"Nass","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119952_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fmolb.2020.00033","article-title":"Is it time to start transitioning from 2D to 3D cell culture?","volume":"7","author":"Jensen","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2026.119952_bib3","first-page":"910","article-title":"2D and 3D cell cultures\u2014a comparison of different types of cancer cell cultures","volume":"14","author":"Kapa\u0142czy\u0144ska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.biopha.2026.119952_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drudis.2012.10.003","article-title":"Three-dimensional cell culture: The missing link in drug discovery","volume":"18","author":"Breslin","year":"2013","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.biopha.2026.119952_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fphar.2018.00006","article-title":"Three-dimensional in vitro cell culture models in drug discovery and drug repositioning","volume":"9","author":"Langhans","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119952_bib6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/pharmaceutics12121186","article-title":"Three-dimensional spheroids as in vitro preclinical models for cancer research","volume":"12","author":"Pinto","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119952_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1741-7007-10-29","article-title":"Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation","volume":"10","author":"Vinci","year":"2012","journal-title":"BMC Biol."},{"key":"10.1016\/j.biopha.2026.119952_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based drug screen: Considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2026.119952_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pharmthera.2017.10.018","article-title":"Emerging tumor spheroid technologies for 3D in vitro cancer modeling","volume":"184","author":"Rodrigues","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2026.119952_bib10","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.biotechadv.2016.11.002","article-title":"3D tumor spheroids: An overview on the tools and techniques used for their analysis","volume":"34","author":"Costa","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biopha.2026.119952_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep19103","article-title":"3D tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained","volume":"6","author":"Zanoni","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119952_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","article-title":"Three-dimensional culture systems in cancer research: Focus on tumor spheroid model","volume":"163","author":"Nath","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2026.119952_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jbiotec.2010.01.012","article-title":"Multicellular tumor spheroids: An underestimated tool is catching up again","volume":"148","author":"Hirschhaeuser","year":"2010","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119952_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour microenvironment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119952_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay. Drug. Dev. Technol."},{"key":"10.1016\/j.biopha.2026.119952_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2012.04.045","article-title":"Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy","volume":"164","author":"Mehta","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119952_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/bit.26845","article-title":"3D tumor spheroids as in vitro models to mimic in vivo human solid tumor resistance to therapeutic drugs","volume":"116","author":"Nunes","year":"2019","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biopha.2026.119952_bib18","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.3390\/cancers13122970","article-title":"vitro 3D cultures to model the tumor microenvironment","volume":"13","author":"Fontana","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119952_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1507388","article-title":"Breaking the mold: 3D cell cultures reshaping the future of cancer research","volume":"12","author":"Cordeiro","year":"2024","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119952_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202370097","article-title":"3D biomimetic models to reconstitute tumor microenvironment in vitro: Spheroids, organoids, and tumor-on-a-chip","volume":"12","author":"Li","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2026.119952_bib21","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/biomedicines11041058","article-title":"Replacement, Reduction, and Refinement of animal experiments in anticancer drug development: The contribution of 3D in vitro cancer models in drug efficacy assessment","volume":"11","author":"Tosca","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119952_bib22","unstructured":"W.M.S. Russell, R.L. Burch, The Principles of Humane Experimental Technique, Methuen, London, 1959."},{"key":"10.1016\/j.biopha.2026.119952_bib23","unstructured":"U.S. Congress, Consolidated Appropriations Act, 2023, Pub. L. No. 117-328, \u00a7 3209, 136 Stat. 4459 (2022)."},{"key":"10.1016\/j.biopha.2026.119952_bib24","unstructured":"U.S. Food and Drug Administration, Roadmap to Reducing Animal Testing in Preclinical Safety Studies, U.S. Food and Drug Administration, Silver Spring, MD, 2025."},{"key":"10.1016\/j.biopha.2026.119952_bib25","series-title":"OECD Series on Testing and Assessment","article-title":"Guidance Document on Good In Vitro Method Practices (GIVIMP)","author":"OECD","year":"2025"},{"key":"10.1016\/j.biopha.2026.119952_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111047","article-title":"Systematic screening of synthetic organochalcogen compounds with anticancer activity using human lung adenocarcinoma spheroids","volume":"396","author":"Batista","year":"2024","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.biopha.2026.119952_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2020.151095","article-title":"Simplified low-cost methodology to establish, histologically process and analyze three-dimensional cancer cell spheroid arrays","volume":"99","author":"Moraes","year":"2020","journal-title":"Eur. J. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119952_bib28","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/201367","article-title":"Cellular responses to cisplatin-induced DNA damage","volume":"2010","author":"Basu","year":"2010","journal-title":"J. Nucleic Acids"},{"key":"10.1016\/j.biopha.2026.119952_bib29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119952_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119952_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biopha.2026.119952_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044640","article-title":"Development of multicellular tumor spheroid culture from breast cancer cells and a high-throughput screening method using the MTT assay","volume":"7","author":"Ho","year":"2012","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119952_bib33","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/bjc.2016.385","article-title":"The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug","volume":"115","author":"Sacco","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119952_bib34","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3892\/ol.2015.3450","article-title":"Meformin inhibits growth of lung adenocarcinoma cells by inducing apoptosis via the mitochondria-mediated pathway","volume":"10","author":"Wang","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2026.119952_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101945","article-title":"Metformin as anticancer agent and adjuvant in cancer combination therapy: current progress and future prospect","volume":"44","author":"Zhu","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.biopha.2026.119952_bib36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/cimb48030286","article-title":"From metabolism to longevity: molecular mechanisms underlying metformin\u2019s anticancer and anti-agin effects","volume":"48","author":"Vujovic","year":"2026","journal-title":"Curr. Issues Mol. Bol."},{"key":"10.1016\/j.biopha.2026.119952_bib37","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.18632\/oncotarget.13857","article-title":"Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment","volume":"8","author":"D\u00e4ster","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119952_bib38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrc1893","article-title":"Drug penetration in solid tumours","volume":"6","author":"Minchinton","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119952_bib39","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119952_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2407-13-73","article-title":"Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D","volume":"13","author":"Laurent","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2026.119952_bib41","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jnci\/djm135","article-title":"Drug resistance and the solid tumor microenvironment","volume":"99","author":"Tr\u00e9dan","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2026.119952_bib42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41571-023-00745-2","article-title":"Functional precision oncology using patient-derived assays: Bridging genotype and phenotype","volume":"20","author":"van Renterghem","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119952_bib43","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/cells12071001","article-title":"Cancer spheroids and organoids as novel tools for research and therapy: state of the art and challenges to guide precision medicine","volume":"12","author":"El Harane","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119952_bib44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:01:29Z","timestamp":1794744089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":44,"alternative-id":["S0753332226009881"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119952","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spheroid maturation determines drug response and establishes a mechanism-informed framework for analytical endpoint validation in three-dimensional lung cancer models","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119952"}}